These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26732221)

  • 1. [Which is the preferred perioperative beta-blocker?].
    van Klei WA
    Ned Tijdschr Geneeskd; 2015; 159():A9798. PubMed ID: 26732221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative β-blockade: atenolol is associated with reduced mortality when compared to metoprolol.
    Wallace AW; Au S; Cason BA
    Anesthesiology; 2011 Apr; 114(4):824-36. PubMed ID: 21372680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Beta-Blocker Initiation Timing on Mortality Risk in Patients With Diabetes Mellitus Undergoing Noncardiac Surgery: A Nationwide Population-Based Cohort Study.
    Chen RJ; Chu H; Tsai LW
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28073770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective β1-antagonism with bisoprolol is associated with fewer postoperative strokes than atenolol or metoprolol: a single-center cohort study of 44,092 consecutive patients.
    Ashes C; Judelman S; Wijeysundera DN; Tait G; Mazer CD; Hare GM; Beattie WS
    Anesthesiology; 2013 Oct; 119(4):777-87. PubMed ID: 23820187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of differing perioperative beta-blockade strategies in vascular surgery patients.
    Fleisher LA; Corbett W; Berry C; Poldermans D
    J Cardiothorac Vasc Anesth; 2004 Feb; 18(1):7-13. PubMed ID: 14973792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perioperative metoprolol and risk of stroke after noncardiac surgery.
    Mashour GA; Sharifpour M; Freundlich RE; Tremper KK; Shanks A; Nallamothu BK; Vlisides PE; Weightman A; Matlen L; Merte J; Kheterpal S
    Anesthesiology; 2013 Dec; 119(6):1340-6. PubMed ID: 23612244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How often should atenolol be dosed for perioperative ß-blockade?
    Badgett RG; Lawrence VA; Cohn SL
    Anesthesiology; 2011 Nov; 115(5):1140; author's reply 1140-1. PubMed ID: 22027634
    [No Abstract]   [Full Text] [Related]  

  • 8. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy and safety of different beta-blockers in patients with isolated systolic hypertension associated with diabetes mellitus and obstructive pulmonary diseases].
    Kukes VG; Ostroumova OD; Mamaev VI; Batutina AM; Abakumov IuE; Zykova AA
    Ter Arkh; 2003; 75(8):43-7. PubMed ID: 14520850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The experts debate: perioperative beta-blockade for noncardiac surgery--proven safe or not?
    Poldermans D; Devereaux PJ
    Cleve Clin J Med; 2009 Nov; 76 Suppl 4():S84-92. PubMed ID: 20064814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Diabetic Postoperative Mortality and Morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery.
    Juul AB; Wetterslev J; Kofoed-Enevoldsen A; Callesen T; Jensen G; Gluud C;
    Am Heart J; 2004 Apr; 147(4):677-83. PubMed ID: 15077084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta blockers for elective surgery in elderly patients: population based, retrospective cohort study.
    Redelmeier D; Scales D; Kopp A
    BMJ; 2005 Oct; 331(7522):932. PubMed ID: 16210252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blocker-induced psoriasis: a rare side effect--a case report.
    Yilmaz MB; Turhan H; Akin Y; Kisacik HL; Korkmaz S
    Angiology; 2002; 53(6):737-9. PubMed ID: 12463630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CNS-related subjective symptoms during treatment with beta 1-adrenoceptor antagonists (atenolol, metoprolol): two double-blind placebo controlled studies.
    Dimenäs E; Dahlöf C; Olofsson B; Wiklund I
    Br J Clin Pharmacol; 1989 Nov; 28(5):527-34. PubMed ID: 2574052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Atenolol or metoprolol as beta-blocker in the treatment of hypertension].
    van den Born BJ; Brewster LM; Koopmans RP; van Montfrans GA
    Ned Tijdschr Geneeskd; 2005 Aug; 149(32):1808-9. PubMed ID: 16121668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial.
    ; Devereaux PJ; Yang H; Yusuf S; Guyatt G; Leslie K; Villar JC; Xavier D; Chrolavicius S; Greenspan L; Pogue J; Pais P; Liu L; Xu S; Málaga G; Avezum A; Chan M; Montori VM; Jacka M; Choi P
    Lancet; 2008 May; 371(9627):1839-47. PubMed ID: 18479744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between simvastatin and metoprolol with respect to cardiac beta-adrenoceptor density, catecholamine levels and perioperative catecholamine requirements in cardiac surgery patients.
    Nette AF; Abraham G; Ungemach FR; Oertel R; Kirch W; Leineweber K; Mohr FW; Dhein S
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Aug; 372(2):115-24. PubMed ID: 16215713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimising the use of beta-adrenoceptor antagonists in coronary artery disease.
    Ellison KE; Gandhi G
    Drugs; 2005; 65(6):787-97. PubMed ID: 15819591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group.
    Poldermans D; Boersma E; Bax JJ; Thomson IR; van de Ven LL; Blankensteijn JD; Baars HF; Yo TI; Trocino G; Vigna C; Roelandt JR; van Urk H
    N Engl J Med; 1999 Dec; 341(24):1789-94. PubMed ID: 10588963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carvedilol: a third-generation β-blocker should be a first-choice β-blocker.
    DiNicolantonio JJ; Hackam DG
    Expert Rev Cardiovasc Ther; 2012 Jan; 10(1):13-25. PubMed ID: 22149523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.